{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:56:44Z","timestamp":1778914604738,"version":"3.51.4"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.3201\/eid2408.180460","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T13:36:25Z","timestamp":1530538585000},"page":"1594-1596","source":"Crossref","is-referenced-by-count":34,"title":["Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab"],"prefix":"10.3201","volume":"24","author":[{"given":"Martin","family":"Martinot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Ahle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inesa","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragos M.","family":"Gorun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Mohseni-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Fafi-Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Tebacher-Alt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2408.180460-201807171155-R1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cei.12948","article-title":"Progressive multi-focal leucoencephalopathy\u00a0-\u00a0driven from rarity to clinical mainstream by iatrogenic immunodeficiency.","volume":"188","author":"Misbah","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"key-10.3201\/eid2408.180460-201807171155-R2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/eji.201646875","article-title":"Immune checkpoints and their inhibition in cancer and infectious diseases.","volume":"47","author":"Dyck","year":"2017","journal-title":"Eur J Immunol"},{"key":"key-10.3201\/eid2408.180460-201807171155-R3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/23808993.2017.1380517","article-title":"Checkpoint inhibitors and the risk of infection.","volume":"2","author":"McCarthy","year":"2017","journal-title":"Expert Review of Precision Medicine and Drug Development."},{"key":"key-10.3201\/eid2408.180460-201807171155-R4","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.cmi.2018.01.030","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).","volume":"24","author":"Redelman-Sidi","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2408.180460-201807171155-R5","doi-asserted-by":"publisher","first-page":"67782","DOI":"10.18632\/oncotarget.18847","article-title":"Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities.","volume":"8","author":"Costa","year":"2017","journal-title":"Oncotarget"},{"key":"key-10.3201\/eid2408.180460-201807171155-R6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature.","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur J Cancer"},{"key":"key-10.3201\/eid2408.180460-201807171155-R7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijid.2017.01.028","article-title":"Anti-PD-1\/PD-L1 therapy for infectious diseases: learning from the cancer paradigm.","volume":"56","author":"Rao","year":"2017","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2408.180460-201807171155-R8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/QAI.0b013e31825a313c","article-title":"Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.","volume":"60","author":"Tan","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid2408.180460-201807171155-R9","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/cid\/ciw539","article-title":"The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma.","volume":"63","author":"Del Castillo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2408.180460-201807171155-R10","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/24\/8\/18-0460_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:24:46Z","timestamp":1732987486000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/24\/8\/18-0460_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2408.180460","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}